ANTIMICROBIAL TECHNOLOGIES & DRUG DELIVERY PLATFORMS
With
Associate Professor Aaron Elbourne, RMIT University, Melbourne, Australia
RESEARCHER PROFILE
Filmed in Melbourne, Australia | January 2026
Dr Aaron Elbourne is an ARC DECRA Fellow, Jack Brockhoff ECR Fellow, and Associate Professor within the School of Science at STEM Hub. A leader in nanomaterials, soft matter science, and interface research, Aaron’s work addresses critical challenges in health and the environment.
Since becoming an independent researcher, Aaron has held continuous funding from prestigious funders, including the Australian Research Council (ARC) and the National Health and Medical Research Council (NHMRC). His research is characterised by its interdisciplinary approach, combining chemistry, materials science, and engineering. His pioneering contributions to colloid therapeutics and soft matter science have driven advancements in diagnostic tools, antimicrobial technologies, and therapeutic delivery systems. His expertise in studying nanomaterial interactions with synthetic and biological membranes has been instrumental in translating scientific discoveries into impactful applications.
Aaron is a dedicated mentor to early-career researchers (ECRs) and students, having supervised and trained numerous postgraduate and doctoral candidates. He has played a key role in securing funding for student training initiatives, including joint PhD scholarships and National Industry PhD programs, which emphasise collaboration between academia and industry.
With a strong focus on translational research, Aaron’s work bridges the gap between fundamental science and practical applications. His leadership in creating innovative technologies, fostering academic-industry partnerships, and empowering future researchers underscores his commitment to advancing science and creating a meaningful impact.
Source: Supplied
https://orcid.org/0000-0002-8562-7325
-
Pancreatic and lung cancers driven by mutations in the cancer gene KRAS
Dr Mara Zeissig is a recently appointed Lab Head within the Tumour Inflammation and Immunotherapy Program at the South Australian immunoGENomics Cancer Institute (SAiGENCI).
Her research focuses on studying immune evasion mechanisms in lung and pancreatic cancers to identify novel ways to increase response to immunotherapy. Her expertise is in genetically engineered mouse models of lung cancer, CRISPR-Cas9 screening technologies and T cell based immunotherapies (e.g Checkpoint inhibitors). -
Dr Jade Murray
DR JADE MURRAY, POSTDOCTORAL RESEARCH FELLOW
TURNER INSTITUTE FOR BRAIN AND MENTAL HEALTH, MONASH UNIVERSITY
VICTORIA, AUSTRALIA -
Cancer survivorship and exercise oncology
Professor Sandra Hayes is the Director of Research at Cancer Council Queensland (CCQ), where she leads a comprehensive cancer research program encompassing cancer epidemiology, prevention, detection, treatment, and survivorship.
With a BAppSci (Hons) and a PhD in exercise oncology, Professor Hayes’s expertise lies in quantifying the impact of cancer diagnosis and treatment on physical and psychosocial wellbeing, quality of life, and survival. She also evaluates innovative supportive care strategies, particularly exercise, to improve post-cancer lives.
